NMR Reaction-Monitoring as a Process Analytical Technique - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

NMR Reaction-Monitoring as a Process Analytical Technique
The authors describe the benefits of nuclear magnetic resonance (NMR) compared with traditional monitoring techniques. They also discuss how NMR reaction monitoring provides a new process analytical technology tool for industry.

Pharmaceutical Technology
pp. s19-s21


1. M.A. Bernstein, Spectrosc. Eur. 19, 11–13 (2007).

2. S.K. Kuster, E. Danieli, B. Blumich, and F. Casanova, Phys. Chem. Chem. Phys. 13, 13172–13176 (2011).

3. M. Maiwald, H. H. Fischer, Y.K. Kim, K. Albert, and H. Hasse, Jrnl. Magn. Reson. 166 (2) 135–146 (2004).

4. M.A. Bernstein, M. Stefinovic, and C.J. Sleigh, Magn. Reson. Chem. 45 (7) 564–571 (2007).

5. J. Sudmeier, U.L. Gunther, K. Albert, and W. Bachovchin, Jrnl. Mag. Res. A, 118 (2) 145–156 (1996).

6. D.B. Green, J. Lane, and R.M. Wing, Appl. Spectrosc. 41 (5) 847–851 (1987).

7. M. Khajeh, M. A. Bernstein, and G. A. Morris, Magn. Reson. Chem. 48 (7) 516–522 (2010).

8. Mestrelab Research, http://mestrelab.com/.

9. M. Zell et al., presentation at SMASH—Small Molecule NMR Conference (Portland, 2010).

10. D.A. Foley et al., J. Org. Chem. (2011) in press.

11. A.C. Barrios Sosa et al., Org. Process Res. Dev. 15 (4) 444–454 (2011).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here